| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-11 |
| mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.25 |
7e-08 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-07 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.26 |
1e-06 |
| mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
0.3 |
9e-06 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |